Ang-2-VEGF-A CrossMab, a Novel Bispecific Human IgG1 Antibody Blocking VEGF-A and Ang-2 Functions Simultaneously, Mediates Potent Antitumor, Antiangiogenic, and Antimetastatic Efficacy

Y. Kienast, C. Klein, W. Scheuer, R. Raemsch, E. Lorenzon, D. Bernicke, F. Herting, S. Yu, H. H. The, L. Martarello, C. Gassner, K.-G. Stubenrauch (+3 others)
2013 Clinical Cancer Research  
doi:10.1158/1078-0432.ccr-13-0081 pmid:24097868 fatcat:vh6jasu6djhfzb3xvo4otgzjui